154 related articles for article (PubMed ID: 12606644)
1. Pharmacokinetic/pharmacodynamic modeling of the antinociceptive effects of (+)-tramadol in the rat: role of cytochrome P450 2D activity.
Garrido MJ; Sayar O; Segura C; Rapado J; Dios-Vieitez MC; Renedo MJ; Troconiz IF
J Pharmacol Exp Ther; 2003 May; 305(2):710-8. PubMed ID: 12606644
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effects of main active metabolites of tramadol, (+)-O-desmethyltramadol and (-)-O-desmethyltramadol, in rats.
Valle M; Garrido MJ; Pavón JM; Calvo R; Trocóniz IF
J Pharmacol Exp Ther; 2000 May; 293(2):646-53. PubMed ID: 10773040
[TBL] [Abstract][Full Text] [Related]
3. Modeling of the in vivo antinociceptive interaction between an opioid agonist, (+)-O-desmethyltramadol, and a monoamine reuptake inhibitor, (-)-O-desmethyltramadol, in rats.
Garrido MJ; Valle M; Campanero MA; Calvo R; Trocóniz IF
J Pharmacol Exp Ther; 2000 Oct; 295(1):352-9. PubMed ID: 10992001
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.
Stamer UM; Musshoff F; Kobilay M; Madea B; Hoeft A; Stuber F
Clin Pharmacol Ther; 2007 Jul; 82(1):41-7. PubMed ID: 17361124
[TBL] [Abstract][Full Text] [Related]
5. Postmenstrual age and CYP2D6 polymorphisms determine tramadol o-demethylation in critically ill neonates and infants.
Allegaert K; van Schaik RH; Vermeersch S; Verbesselt R; Cossey V; Vanhole C; van Fessem M; de Hoon J; van den Anker JN
Pediatr Res; 2008 Jun; 63(6):674-9. PubMed ID: 18317231
[TBL] [Abstract][Full Text] [Related]
6. Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antinociceptive response in the presence of competitive antagonism: the interaction between tramadol and its active metabolite on micro-opioid agonism and monoamine reuptake inhibition, in the rat.
Beier H; Garrido MJ; Christoph T; Kasel D; Trocóniz IF
Pharm Res; 2008 Aug; 25(8):1789-97. PubMed ID: 18008149
[TBL] [Abstract][Full Text] [Related]
7. The hypoalgesic effect of tramadol in relation to CYP2D6.
Poulsen L; Arendt-Nielsen L; Brøsen K; Sindrup SH
Clin Pharmacol Ther; 1996 Dec; 60(6):636-44. PubMed ID: 8988065
[TBL] [Abstract][Full Text] [Related]
8. Comparative bioavailability between two Tramadol once-daily oral formulations.
Hernandez-Lopez C; Martinez-Farnos L; Karhu D; Perez-Campos T; Rovira S; Encina G
Methods Find Exp Clin Pharmacol; 2006; 28(6):373-8. PubMed ID: 16894407
[TBL] [Abstract][Full Text] [Related]
9. Unexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochloride.
Raffa RB; Haslego ML; Maryanoff CA; Villani FJ; Codd EE; Connelly CD; Martinez RP; Schupsky JJ; Buben JA; Wu WN; Takacs AN; Mckown LA
J Pharmacol Exp Ther; 1996 Sep; 278(3):1098-104. PubMed ID: 8819491
[TBL] [Abstract][Full Text] [Related]
10. Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol.
Kirchheiner J; Keulen JT; Bauer S; Roots I; Brockmöller J
J Clin Psychopharmacol; 2008 Feb; 28(1):78-83. PubMed ID: 18204346
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of enantiomers of trans-tramadol and its active metabolite, trans-O-demethyltramadol, in human subjects.
Liu HC; Liu TJ; Yang YY; Hou YN
Acta Pharmacol Sin; 2001 Jan; 22(1):91-6. PubMed ID: 11730570
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of tramadol in children].
Saudan S; Habre W
Ann Fr Anesth Reanim; 2007 Jun; 26(6):560-3. PubMed ID: 17524604
[TBL] [Abstract][Full Text] [Related]
13. Route-dependent stereoselective pharmacokinetics of tramadol and its active O-demethylated metabolite in rats.
Parasrampuria R; Vuppugalla R; Elliott K; Mehvar R
Chirality; 2007 Mar; 19(3):190-6. PubMed ID: 17192836
[TBL] [Abstract][Full Text] [Related]
14. Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers.
Li Q; Wang R; Guo Y; Wen S; Xu L; Wang S
J Clin Pharm Ther; 2010 Apr; 35(2):239-47. PubMed ID: 20456744
[TBL] [Abstract][Full Text] [Related]
15. Effect of the cytochrome P450 2D6*10 genotype on the pharmacokinetics of tramadol in post-operative patients.
Xu J; Zhang XC; Lv XQ; Xu YY; Wang GX; Jiang B; Cai L; Cai XJ
Pharmazie; 2014 Feb; 69(2):138-41. PubMed ID: 24640604
[TBL] [Abstract][Full Text] [Related]
16. Gender-related differences in pharmacokinetics of enantiomers of trans-tramadol and its active metabolite, trans-O-demethyltramadol, in rats.
Liu HC; Jin SM; Wang YL
Acta Pharmacol Sin; 2003 Dec; 24(12):1265-9. PubMed ID: 14653955
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of tramadol and the metabolite O-desmethyltramadol in dogs.
KuKanich B; Papich MG
J Vet Pharmacol Ther; 2004 Aug; 27(4):239-46. PubMed ID: 15305853
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of tramadol and o-desmethyltramadol in goats after intravenous and oral administration.
de Sousa AB; Santos AC; Schramm SG; Porta V; Górniak SL; Florio JC; de Souza Spinosa H
J Vet Pharmacol Ther; 2008 Feb; 31(1):45-51. PubMed ID: 18177318
[TBL] [Abstract][Full Text] [Related]
19. Stereoselectivity in trans-tramadol metabolism and trans-O-demethyltramadol formation in rat liver microsomes.
Liu HC; Wang N; Yu Y; Hou YN
Acta Pharmacol Sin; 2003 Jan; 24(1):85-90. PubMed ID: 12511234
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective pharmacokinetic analysis of tramadol and its main phase I metabolites in healthy subjects after intravenous and oral administration of racemic tramadol.
García Quetglas E; Azanza JR; Cardenas E; Sádaba B; Campanero MA
Biopharm Drug Dispos; 2007 Jan; 28(1):19-33. PubMed ID: 17061296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]